Tuberculosis

Whole Genome Sequencing Use in Predicting TB Resistance

By

Benjamin Patterson

Publish Date December 25, 2018

Whole genome sequencing of M tuberculosis isolates can identify complete drug susceptibility profiles, allowing precise treatment in early TB infection.

Could a New Universal Tuberculosis Regimen Help End the TB Pandemic?

By

Benjamin Patterson

Publish Date May 31, 2018

The Lancet Respiratory Medicine staged a debate between proponents and opponents of pan-TB regimens to tackle the current suboptimal worldwide management of TB resistance.

Latent Tuberculosis Testing and Treatment Recommendations

By

Tori Rodriguez, MA, LPC, AHC

Publish Date December 7, 2017

Recommendations for testing and treating latent TB infection have been discussed by a representative from the California Department of Public Health.

Gout Risk During Tuberculosis Treatment Higher With Obesity, CKD, Hyperuricemia

By

Pulmonology Advisor Contributing Writer

Researchers investigated the clinical features and risk factors for gout during tuberculosis treatment in a South Korean population.

Treatment-Decision Score for Children With HIV and Suspected Tuberculosis

By

Bradley van Paridon

A new treatment-decision score for the diagnosis of TB in children with HIV performed well, and when used in an algorithm may facilitate prompt treatment decision making for children at a high risk for mortality.

Isoniazid for Tuberculosis Prevention Increases Risks During HIV+ Pregnancy

Deferring tuberculosis treatment until after delivery appears to be safer option.

CDC: Humans Can Contract Tuberculosis From Deer

Anyone working closely with animals that might carry the infection should be screened for tuberculosis.

Elderly Patients Able to Complete Latent Tuberculosis Therapy

By

Sheila Jacobs

Treatment for latent tuberculosis infection among patients between age 65 and 78 years has been shown to be relatively well tolerated, with completion rates decreasing according to age.

Treatment to Prevent Active Tuberculosis Could Be Beneficial to Millions

Revised estimate based on the National Health and Nutrition Examination Survey for prevalence of latent tuberculosis infection excludes those who report prior treatment.

Rifampin and Isoniazid Is Efficacious in Treatment of Pleural Tuberculosis

By

Zahra Masoud

As a result of low drug resistance in pleural tuberculosis, treatment regimens of pleural TB may include fewer drugs and maintain appropriate levels of efficaciousness.

Tuberculosis Rates for US Children Are Low and Declining

Disparities in tuberculosis rates persist by race, ethnicity, and geography.